SB-203580

SB-203580
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-S0500.5 5 mg -

3 - 8 business days*

108.00€
LKT-S0500.25 25 mg -

3 - 8 business days*

375.00€
 
SB-203580 is an inhibitor of p38 MAPK that exhibits immunostimulatory, anticancer, and... more
Product information "SB-203580"
SB-203580 is an inhibitor of p38 MAPK that exhibits immunostimulatory, anticancer, and anti-fibrotic activities. In peripheral blood mononuclear cells, SB-203580 increases secretion of IFN- . In lung epithelial cells, SB-203580 inhibits TGB- 1-induced epithelial-to-mesenchymal transition (EMT). Additionally, SB-203580 inhibits proliferation in glioma cells and decreases angiotensin II- and TGB- 1-induced expression of GTGF and fibronectin in other cellular models.
Keywords: SB203580
Supplier: LKT Laboratories
Supplier-Nr: S0500

Properties

Application: p38 MAP kinase inhibitor
MW: 377.43 D
Purity: >98%
Format: Solid

Database Information

CAS : 152121-47-6| Matching products
KEGG ID : K04441 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H302, H318
P Phrases: P264, P270, P280, P301, P305, P310, P312, P330, P338, P351, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SB-203580"
Write a review
or to review a product.
Viewed